HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Hinge Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$103.96+4.80 (+4.84%)
Close on Oct 19, 2026
- Market cap
- $8.67B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$54.68 (+111.0%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Hinge Health, Inc. grew revenue 49.8% to $720.06M over the twelve months to Jun 30, 2026. Free cash flow was $290.12M, up 218.2% from a year earlier.
Revenue
$720.06M
+49.8% vs. a year earlier
Operating income
$93.67M
TTM Q2 2026
Free cash flow
$290.12M
+218.2% vs. a year earlier
EPS, diluted
-$7.77
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $8.67B
- P/E ratio
- –
- Price to sales
- 12.04
- Price to book
- 25.19
- Dividend yield
- –
- Free cash flow yield
- 3.35%
Fundamentals
- Revenue
- $720.06M
- Net income
- $109.07M
- EPS, diluted
- -$7.77
- Free cash flow
- $290.12M
- Book value per share
- $4.13
- Diluted shares
- 83M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$720.06M+49.8% YoY
Gross profit
$608.41M+63.0% YoY
Operating income
$93.67M
Net income
$109.07M
EPS, diluted
–
Free cash flow
$290.12M+218.2% YoY
Reported periodTrailing twelve months